Journal Information
Most often read
70573
Diaphragmatic dysfunctionJ. Ricoy, N. Rodríguez-Núñez, J.M. Álvarez-Dobaño, M.E. Toubes, V. Riveiro, L. Valdés
Pulmonol. 2019;25:223-35
70573
Open access
54003
New drugs and perspectives for new anti-tuberculosis regimensS. Tiberi, M. Muñoz-Torrico, R. Duarte, M. Dalcolmo, L. D’Ambrosio, G.-B. Migliori
Pulmonol. 2018;24:86-98
54003
Open access
45617
WITHDRAWN: Covid-19: Round and oval areas of ground-glass opacityW. Schmitt, E. Marchiori
45617
Open access
Available online 26 April 2020
43032
COPD exacerbations: management and hospital dischargeA.J. Reis, C. Alves, S. Furtado, J. Ferreira, M. Drummond, C. Robalo-Cordeiro
Pulmonol. 2018;24:345-50
43032
Open access
38699
Tuberculosis and gender – Factors influencing the risk of tuberculosis among men and women by age groupR. Marçôa, A.I. Ribeiro, I. Zão, R. Duarte
Pulmonol. 2018;24:199-202
38699
Open access
34218
Respiratory function in patients post-infection by COVID-19: a systematic review and meta-analysisR. Torres-Castro, L. Vasconcello-Castillo, X. Alsina-Restoy, L. Solis-Navarro, F. Burgos, H. Puppo, J. Vilaró
Pulmonol. 2021;27:328-37
34218
Open access
Open Article
31948
Tuberculosis and COVID-19 interaction: A review of biological, clinical and public health effectsD. Visca, C.W.M. Ong, S. Tiberi, R. Centis, L. D’Ambrosio, B. Chen, J. Mueller, P. Mueller, ... D. Goletti
Pulmonol. 2021;27:151-65
31948
Open access
Open Article
31055
Identification and assessment of COPD exacerbationsA.S. Oliveira, J. Munhá, A. Bugalho, M. Guimarães, G. Reis, A. Marques
Pulmonol. 2018;24:42-7
31055
Open access
30746
COPD and Cardiovascular DiseaseS. André, B. Conde, E. Fragoso, J.P. Boléo-Tomé, V. Areias, J. Cardoso
Pulmonol. 2019;25:168-76
30746
Open access
26931
Tuberculosis, social determinants and co-morbidities (including HIV)R. Duarte, K. Lönnroth, C. Carvalho, F. Lima, A.C.C. Carvalho, M. Muñoz-Torrico, R. Centis
Pulmonol. 2018;24:115-9
26931
Open access
23986
COVID-19 pandemic and non invasive respiratory management: Every Goliath needs a David. An evidence based evaluation of problemsJ.C. Winck, N. Ambrosino
Pulmonol. 2020;26:213-20
23986
Open access
23840
The immune response to SARS-CoV-2 and COVID-19 immunopathology – Current perspectivesJ.L. Boechat, I. Chora, A. Morais, L. Delgado
Pulmonol. 2021;27:423-37
23840
Open access
23491
Medical masks and Respirators for the Protection of Healthcare Workers from SARS-CoV-2 and other virusesMariachiara Ippolito, Filippo Vitale, Giuseppe Accurso, Pasquale Iozzo, Cesare Gregoretti, Antonino Giarratano, Andrea Cortegiani
Pulmonol. 2020;26:204-12
23491
Open access
21812
The Bronchiectasis Severity Index and FACED score for assessment of the severity of bronchiectasisJ.C. Costa, J.N. Machado, C. Ferreira, J. Gama, C. Rodrigues
Pulmonol. 2018;24:149-54
21812
Open access
21629
Pirfenidone and Nintedanib in idiopathic pulmonary fibrosis: Real-life experience in an Italian referral centreE. Bargagli, C. Piccioli, E. Rosi, E. Torricelli, L. Turi, E. Piccioli, M. Pistolesi, K. Ferrari, L. Voltolini
Pulmonol. 2019;25:149-53
21629
Open access
21299
Use of Helmet CPAP in COVID-19 – A practical reviewH. Amirfarzan, M. Cereda, T.G. Gaulton, K.B. Leissner, A. Cortegiani, R. Schumann, C. Gregoretti
Pulmonol. 2021;27:413-22
21299
Open access
Open Article
21216
Covid-19: Round and oval areas of ground-glass opacityW. Schmitt, E. Marchiori
Pulmonol. 2020;26:246-7
21216
Open access
20642
Regulations on e-cigarettes: China is taking actionY. Cao, H. Yi, J. Zhou, Y. Cheng, Y. Mao
Pulmonol. 2023;29:359-61
20642
Full text access
20205
Role of bronchoscopy in foreign body aspiration management in adults: A seven year retrospective studyC. Costa, S. Feijó, P. Monteiro, L. Martins, J.Rosal. Gonçalves
Pulmonol. 2018;24:50-2
20205
Open access
19995
COVID-19 and asthma: To have or not to have T2 inflammation makes a difference?M. Morais-Almeida, J. Bousquet
Pulmonol. 2020;26:261-3
19995
Open access